Lotus Pharmaceuticals, Inc.
Lotus Pharmaceuticals, Inc. (Lotus) is engaged in the development, manufacture and distribution of prescription drugs and pharmaceutical products. It operates and has ownership interests in Liang Fang Pharmaceutical, Ltd. (Liang) and En Zhe Jia Shi Pharmaceutical, Ltd. (En Zhe). Liang and En Zhe are collectively refereed as Lotus East and are together engaged in the production, trade, sales and marketing of pharmaceuticals. In China, both companies possess some of the most advanced pharmaceutical-production equipment. The company owns and operates 10 drug stores in Beijing, China, engaged in the sale of western and traditional Chinese medications, lease medical treatment facilities. Its current drug development pipeline has major focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The company is headquartered at Beijing, China.